受强制性开放获取政策约束的文章 - Ou Yi-Hsuan了解详情
无法在其他位置公开访问的文章：1 篇
Redox-Active Organoruthenium(II)– and Organoosmium(II)–Copper(II) Complexes, with an Amidrazone–Morpholine Hybrid and [CuICl2]− as Counteranion and …
K Ohui, MV Babak, D Darvasiova, A Roller, D Vegh, P Rapta, GRS Guan, ...
Organometallics 38 (10), 2307-2318, 2019
强制性开放获取政策： Austrian Science Fund
可在其他位置公开访问的文章：3 篇
Extracellular vesicles in cardiovascular diseases: alternative biomarker sources, therapeutic agents, and drug delivery carriers
SY Chong, CK Lee, C Huang, YH Ou, CJ Charles, AM Richards, ...
International journal of molecular sciences 20 (13), 3272, 2019
强制性开放获取政策： National Medical Research Council, Singapore
Cell-derived nanovesicles as exosome-mimetics for drug delivery purposes: uses and recommendations
YH Ou, S Zou, WJ Goh, JW Wang, M Wacker, B Czarny, G Pastorin
Bio-Carrier Vectors: Methods and Protocols, 147-170, 2021
强制性开放获取政策： A*Star, Singapore
Micro cell vesicle technology (mCVT): A novel hybrid system of gene delivery for hard-to-transfect (HTT) cells
YH Ou, S Zou, WJ Goh, SY Chong, G Venkatesan, MG Wacker, G Storm, ...
Nanoscale 12 (35), 18022-18030, 2020
强制性开放获取政策： National Medical Research Council, Singapore
出版信息和资助信息由计算机程序自动确定